AMOXICILLINE/ACIDE CLAVULANIQUE BGR 500 mg/62.5 mg for adults, film-coated tablet (ratio amoxicillin/clavulanic acid : 8/1) 16 tablets
Active ingredients: Clavulanic acid, Amoxicillin, Amoxicillin trihydrate, Clavulanate potassium
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet16 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AMOXICILLINE/ACIDE CLAVULANIQUE BGR 500 mg/62,5 mg ADULTES, comprimé pelliculé (Rapport amoxicilline/acide clavulanique : 8/1)
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) aluminium polyéthylène de 16 comprimé(s)
- Marketing authorisation holder
- BIOGARAN
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 7 Jan 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66921126CIP73773412CIP133400937734127Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| AMOXICILLINE BASEcomprimé | 500,00 mg · un comprimé | FT |
| AMOXICILLINE TRIHYDRATÉEcomprimé | — | SA |
| CLAVULANATE DE POTASSIUMcomprimé | — | SA |
| ACIDE CLAVULANIQUEcomprimé | 62,50 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.